Mutation analysis of the MET proto-oncogene and the von Hippel-Lindau (VHL) tumour suppressor gene in familial renal cell carcinoma.

被引：0
|
作者：
Woodward, E
Rose, S
Schmidt, L
Affara, NA
Maher, ER
机构：
[1] UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1TN,ENGLAND
[2] BIRMINGHAM WOMENS HOSP,REG MOL GENET LAB,BIRMINGHAM B15 2TG,W MIDLANDS,ENGLAND
[3] NCI,IMMUNOBIOL LAB,BETHESDA,MD 20892
[4] UNIV BIRMINGHAM,DEPT PAEDIAT & CHILD HLTH,DIV MED GENET,BIRMINGHAM B15 2TG,W MIDLANDS,ENGLAND
来源：
JOURNAL OF MEDICAL GENETICS | 1997年 / 34卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [41] Targeting von Hippel-Lindau pathway in renal cell carcinoma
    Patel, Premal H.
    Chadalavada, Rajendrakumar S. V.
    Chaganti, R. S. K.
    Motzer, Robert J.
    CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7215 - 7220
  • [42] Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease
    Jonasch, Eric
    Donskov, Frede
    Iliopoulos, Othon
    Rathmell, W. Kimryn
    Narayan, Vivek K.
    Maughan, Benjamin L.
    Oudard, Stephane
    Else, Tobias
    Maranchie, Jodi K.
    Welsh, Sarah J.
    Thamake, Sanjay
    Park, Eric K.
    Perini, Rodolfo F.
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (22): : 2036 - 2046
  • [43] Von Hippel-Lindau disease and sporadic renal cell carcinoma
    Zbar, B
    CANCER SURVEYS, 1995, 25 : 219 - 232
  • [44] Precision surgery for Von Hippel-Lindau renal cell carcinoma
    Larcher, A.
    Belladelli, F.
    Fallara, G.
    Rowe, I.
    Ieva, A.
    Santangelo, M.
    Luciano, R.
    Doglioni, C.
    Mattioli, C.
    Sciarrone Alibrandi, M. T.
    Guazzarotti, G.
    Damascelli, A.
    Bellin, A.
    Canibus, D.
    Capitanio, U.
    Montorsi, F.
    De Cobelli, F.
    Bertini, R.
    Salonia, A.
    EUROPEAN UROLOGY, 2022, 81
  • [45] Management of renal cell carcinoma in von Hippel-Lindau disease
    Hes, FJ
    Slootweg, PJ
    van Vroonhoven, TJMV
    Hené, RJ
    Feldberg, MAM
    Zewald, RA
    van Amstel, JKP
    Höppener, JWM
    Pearson, PL
    Lips, CJM
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1999, 29 (01) : 68 - 75
  • [46] RENAL-CELL CARCINOMA IN VON HIPPEL-LINDAU SYNDROME
    MALEK, RS
    OMESS, PJ
    BENSON, RC
    ZINCKE, H
    AMERICAN JOURNAL OF MEDICINE, 1987, 82 (02): : 236 - 238
  • [47] Pathogenicity of germline VHL variants is associated with renal cell carcinoma size in von Hippel-Lindau disease
    Mori, Gustavo H.
    Fagundes, Gustavo F. C.
    Santana, Lucas S.
    Freitas-Castro, Felipe
    Afonso, Ana Caroline F.
    Lourenco, Delmar M.
    Pereira, Maria Adelaide A.
    Tanno, Fabio Y.
    Srougi, Victor
    Chambo, Jose L.
    Cordeiro, Mauricio D.
    Nahas, William C.
    Hoff, Ana O.
    Fragoso, Maria Candida B. V.
    Mendonca, Berenice B.
    Latronico, Ana Claudia
    Almeida, Madson Q.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2025, 69
  • [48] Two single nucleotide polymorphisms in the von Hippel-Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma
    Wang W.-C.
    Tsou M.-H.
    Chen H.-J.
    Hsu W.-F.
    Lai Y.-C.
    BMC Research Notes, 7 (1)
  • [49] THE VON HIPPEL-LINDAU (VHL) DISEASE TUMOR-SUPPRESSOR GENE IS NOT MUTATED IN NASOPHARYNGEAL CARCINOMAS
    SUN, Y
    HILDESHEIM, A
    LI, H
    LANIER, AP
    CAO, Y
    YAO, KT
    YANG, CS
    COLBURN, NH
    INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (03) : 437 - 438
  • [50] Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
    Ashouri, Kenan
    Mohseni, Sophia
    Tourtelot, John
    Sharma, Pranav
    Spiess, Philippe E.
    JOURNAL OF KIDNEY CANCER AND VHL, 2015, 2 (04): : 163 - 173
12345